A new line of underwear which incorporates a hi-tech moisturising ingredient into its fabric is being test-marketed.

The unnamed product line of intimate apparel, currently being test-marketed by a global company, uses Applied DNA Sciences' (APDN) proprietary DermalRx HydroSeal ingredient.

Part of APDN's BioActive Ingredients portfolio, DermalRx HydroSeal uses "structural moisturisation" to treat dry skin, based on the biofermentation expertise developed from the company's SigNature DNA and BioMaterial Genotyping.

"Topical delivery systems enhance the performance of active ingredients on the skin," said Dr James Hayward, CEO of APDN.

"All garments contact the skin. What better way to deploy a skin treatment than through a textile?"

APDN said DermalRx HydroSeal, a complex of a yeast ferment, soy proteins and soy peptides, helped to enhance cohesion between the cells in the upper layers of the skin, restoring elasticity and the skin's natural capacity to retain moisture.

APDN believes that its BioActive Ingredients products are set to generate a growing future revenue stream for the company.